Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory (FCT). This program demonstrated significant improvements in hypertension treatment and control. The focus of aim 3 will be evaluating diabetes management through the implementation of the HEARTS-D bundle in 10 PHCs across the FCT that previously participated in the initial HTN Program.

NCT Number	NCT07589387
Lead Sponsor	Washington University School of Medicine Collaborators: National Heart, Lung, and Blood Institute (NHLBI), University of Abuja Teaching Hospital
Conditions	Diabete Mellitus
Enrollment	2,800 participants
Start Date	2026-05-01
Primary Completion	2029-04-30 (estimated)
Study Completion	2030-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-15